Home › Coronary Artery Disease › District of Columbia › Washington
Coronary Artery Disease clinical trials in Washington, DC
5 studies for Coronary Artery Disease are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Washington Vascular Specialists - ClinRe 001-136, Takoma Park · 6 mi away
- Jadestone Clinical Research, LLC, Silver Spring · 7 mi away
- Capitol Cardiology Associates PA, Lanham · 11 mi away
Product Surveillance Registry
RecruitingObservational study
- Washington D.C., Washington D.C.
- Hyattsville, Hyattsville · 6 mi away
- Silver Spring, Silver Spring · 7 mi away
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
Recruiting
- MedStar Washington Hospital Center, Washington D.C.
Prevail Global Study
Recruiting
- Medstar Washington Hospital Center, Washington D.C.
Prevent Cardiac Surgery Associated AKI Trial
RecruitingPhase 2
- George Washington University Hospital, Washington D.C.
About Coronary Artery Disease
Coronary artery disease (CAD) is the most common type of heart disease. It can lead to angina and heart attack. Read about symptoms and tests.
More about Coronary Artery Disease on MedlinePlus
Coronary Artery Disease trials in other cities
- New York City, NY21 studies
- Boston, MA16 studies
- Dallas, TX15 studies
- Atlanta, GA15 studies
- Jacksonville, FL14 studies
- Minneapolis, MN13 studies
- Cleveland, OH13 studies
- Nashville, TN11 studies
- Columbus, OH10 studies
- Durham, NC9 studies
- Philadelphia, PA8 studies
- Memphis, TN8 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.